Glucagon-Like Peptide 1–Based Therapies and Risk of Pancreatic Cancer in Patients With Diabetes and ObesityArunkumar Krishnan, Shailendra Pratap Singh, Shyam Thakkar et al.|Pancreas|2022Cited by 17